2
108
G. Farkas et al. / Tetrahedron: Asymmetry 22 (2011) 2104–2109
(
0.005 mmol) was stirred in 5 mL of solvent for 20 min. The cata-
2 4
4.5. [Rh(10) ]BF 12a
lyst solution was then transferred into the autoclave via syringe.
The autoclave was pressurized with hydrogen (5 bar). After stirring
the reaction mixture for 1 h, the hydrogen pressure was released
carefully. The reaction mixture was filtered over a pad of silica
and analyzed by chiral GC. Hydrogenation reactions at 1 bar were
carried out in glass vessels using the procedure described above.
The conversions of the hydrogenation reactions of dimethyl itaco-
nate, acetamidoacrylic acid methyl ester and the enantiomeric ex-
cesses of the products were determined by chiral GC using a
Hewlett Packard HP 4890 D, equipped with b-Dex 255 column
A mixture of 10a (30 mg, 0.0512 mmol) and [Rh(COD)
2
]BF
4
(10.4 mg, 0.0256 mmol) in an NMR tube was dissolved in CDCl
3
.
3
1
1
1
P{ H} NMR (121.495 MHz, CDCl
3
): d = 27.27 (dt, J(Rh,P) =
2
1
121.4 Hz, J(P,P) = 52.3 Hz), 158.48 ppm (dt, J(Rh,P) = 215.0 Hz,
2
J(P,P) = 52.3 Hz).
0
0
4
.6. (2S,4R)-2-Diphenylphosphino-4-{(S)-dinaphtho[2,1-d:1 ,2 -
f][1,3,2]dioxaphosphepin-2-yloxy}-pentane 10b
(
30 m ꢁ 0.25 mm, df = 0.25
2
lm), N as carrier gas, a split/splitless
The title compound was obtained by the procedure described
injector at 250 °C, and a FID at 250 °C. In the case of the hydroge-
nation of dimethyl itaconate retention times at 85 °C isotherm
were 18.8 min for (R), 20.0 min for (S) and 27.6 min for the sub-
strate. In the case of hydrogenation of acetamidoacrylic acid
methyl ester retention times at 140 °C isotherm were 6.7 min for
20
for 10a; white foam. Yield: 75.7%. ½
a
ꢂ
¼ þ344:8 (c 1.05, CH
2
Cl
: C 75.76, H 5.50. Found:
): d = 0.98 (ddd,
J(P,H) = 15.13 Hz, J(H,H) = 6.83 Hz, J(P,H) = 2.29 Hz, 3H, CH ),
), 1.25 (m, diast.
), 2.63 (m, 1H, CH), 4.53 (m, 1H,
2
),
D
mp: 61–66 °C. Anal. Calcd for C37H O P
32 3 2
1
C, 75.66; H, 5.95. H NMR (400.130 MHz, CDCl
3
3
3
6
3
.21 (dd, J(H,H) = 6.14 Hz, 4J(P,H) = 1.83, 3H, CH
3
1
1
3
(
R), 7.4 min for (S) and 5.9 min for the substrate. The conversions
of the hydrogenation reactions of (Z)- -acetamidocinnamic acid
methyl ester, 4-methoxy-(Z)- -acetamidocinnamic acid methyl es-
ter, 2-methoxy-(Z)- -acetamidocinnamic acid methyl ester, and
2 2
H, CH ), 1.75 (m, diast. 1H, CH
a
13
1
CH-O), 7.10–8.00 (aromatic, 22H). C{ H} NMR (100.613 MHz,
CDCl ): d = 16.52 (d, 1C, CH ), 24.28 (d, 1C, CH ), 26.35 (d, 1C,
CH ), 42.29 (dd, 1C, CH), 71.31 (dd, 1C, CH), 122–149 ppm (aro-
matic, 32C).
a
3
3
3
a
2
the enantiomeric excesses of the products were determined by chi-
ral GC using a Hewlett Packard HP 4890 D, equipped with Chiralsil-
31
1
3
P{ H} NMR (161.976 MHz, CDCl ): d = 1.61 (s),
1
49.33 ppm (s).
L
-Val column (25 m ꢁ 0.25 mm, df = 0.12
2
lm), N as carrier gas, a
split/splitless injector at 250 °C, and a FID at 250 °C. Temperature
4
.7. [Rh(COD)(10b)]BF 11b
4
program: 2 min at 140 °C; 2 °C/min from 140 °C to 180 °C;
4
0 min at 180 °C. Retention times were 12.3 min for (R), 13.2 min
for (S), and 22.1 min for (Z)- -acetamidocinnamic acid methyl es-
ter; 25.7 min for (R), 26.3 min for (S) enantiomers, and 53.6 min for
-methoxy-(Z)- -acetamidocinnamic acid methyl ester; 21.9 min
[
Rh(COD)(10b)]BF
4
was obtained by the procedure described
; yellow powder. Yield: 90%, mp 155–
a
for [Rh(COD)(10a)]BF
4
3
1
1
1
60 °C.
3
P{ H} NMR (121.495 MHz, CDCl ): d = 33.82 (dd,
4
a
1
J(Rh,P) = 143.7 Hz, J(P,P) = 51.2 Hz), 130.83 ppm (dd, 1J(Rh,P) =
2
for (R), 22.6 min for (S), and 34.9 min for 2-methoxy-(Z)-a-acetam-
idocinnamic acid methyl ester, respectively.
2
2
64.0 Hz, J(P,P) = 51.2 Hz).
0
0
4.8. [Rh(10b) ]BF 12b
4
.3. (2R,4S)-2-Diphenylphosphino-4-{(S)-dinaphtho[2,1-d:1 ,2 -
2
4
f][1,3,2]dioxaphosphepin-2-yloxy}-pentane 10a
[
Rh(10b)
2
]BF
4
was obtained by the procedure described for
3
1
1
[
Rh(10a)
2
]BF
4
.
P{ H} NMR (121.495 MHz, CDCl
3
): d = 36.69 (dt,
At first, (2R,4S)-4-(diphenylphosphino)-pentane-2-ol 9 (1.9 g,
1
2
1
J(Rh,P) = 127.0 Hz, J(P,P) = 53.5 Hz), 146.21 ppm (dt, J(Rh,P) =
12.7 Hz, J(P,P) = 53.5 Hz).
6
.976 mmol) and triethylamine (0.81 g, 8.00 mmol) were dissolved
2
2
0
in 30 mL of ether at room temperature. Next, H -chlorophosphite
(
2.8 g, 8.00 mmol) was dissolved in 30 mL of ether at ꢀ10 °C. The
0
0
0
0
4
.9. (2S,4R)-2-Diphenylphosphino-4-{(S)-5,5 ,6,6 ,7,7 ,8,8 -
solution of the phosphine was added to the solution of the chloro-
0
0
octahydro-dinaphtho[2,1-d:1 ,2 -f][1,3,2]dioxaphosphepin-2-
phosphite at ꢀ10 °C and stirred for 30 min. The mixture was fil-
yloxy}-pentane 10c
tered through a pad of activated Al
O
2 3
and washed with 4 ꢁ 5
mL of ether. The solvent of the filtrate was removed under reduced
pressure to obtain 2.55 g (yield: 62.2%) of 10a as a white foam.
The title compound was obtained by the procedure described
for 10a starting from the corresponding phosphine and H
2
D
0
8
-chloro-
½
a
C
ꢂ
¼ þ336:6 (c 1.135, CH
2
Cl
2
), mp: 60–63 °C. Anal. Calcd for
2
D
0
1
phosphite; white foam. Yield: 78.9%. ½
CH Cl ), mp: 64 °C. Anal. Calcd for C37
Found: C, 75.02; H, 6.95. H NMR (300.130 MHz, CDCl
3
a
40
ꢂ
¼ þ185:9 (c 1.135,
37
H
32
O
3
P
2
: C, 75.76; H, 5.50. Found: C, 75.34; H, 5.45. H NMR
3
3
(
6
3
3
500.130 MHz, CDCl ): d = 0.94 (dd, J(P,H) = 15.7 Hz, J(H,H) =
.9 Hz, 3H, CH
2
2
H
O
3
P
2
: C, 74.73; H, 6.78.
): d = 0.97
1
3
3
), 1.23 (m, diast. 1H, CH
2
), 1.30 (d, J(H,H) = 6.3 Hz,
3
3
3
(
dd, J(P,C) = 15.1 Hz, J(H,H) = 6.5 Hz, 3H, CH
3
), 1.20 (d, J(H,H) =
, overlapped) 1.58 (m,
), 1.80 (m, diast. 1H, CH , overlapped),
), 2.72 (m, 1H, CH–P, overlapped), 2.72 (m, 2H,
), 2.84 (m, 4H, 2CH ), 4.53 (m, 1H, CH–O), 6.84–7.81 ppm (aro-
matic 14H). C{ H} NMR (75.468 MHz, CDCl ): d = 15.73 (d, 1C,
CH ), 22.53 (s, 1C, CH ), 22.58 (s, 1C, CH ), 22.70 (s, 1C, CH ),
2.74 (s, 1C, CH ), 23.72 (d, 1C, CH ), 25.53 (d, 1C, CH ), 27.84 (d,
C, CH ), 29.41 (s, 2C, CH ), 70.29 (dd, 1C,
H, CH ), 1.71 (m, diast. 1H, CH
3
2
), 2.54 (m, 1H, CH–P), 4.55 (m, 1H,
13
1
6.03 Hz, 3H, CH
2H, CH ), 1.80 (m, 6H, 3CH
2.31 (m, 2H, CH
3 2
), 1.20 (m, diast. 1H, CH
CH–O), 6.93–7.91 ppm (aromatic 22H). C{ H} NMR (75.468 MHz,
CDCl ): d = 15.95 (dd, 1C, CH ), 23.85 (d, 1C, CH ), 25.39 (d, 1C,
CH ), 41.73 (dd, 1C, CH), 70.50 (dd, 1C, CH), 122–148 ppm (aro-
matic 32C).
2
2
2
3
3
3
2
2
3
1
1
CH
2
2
3
P{ H} NMR (121.495 MHz, CDCl ): d = 0.00 (s),
1
3
1
1
53.51 ppm (s).
3
3
2
2
2
2
1
CH
2
3
2
4
.4. [Rh(COD)(10a)]BF
4
11a
2
2
), 41.66 (dd, 1C, CH
2
3
1
1
Ligand 10a (129.9 mg, 0.2216 mmol) dissolved in CH
2
Cl
2
(5 mL)
(90 mg,
2
), 119–147 ppm (aromatic 32C). P{ H} NMR (161.976 MHz,
): d = ꢀ0.01 (s), 142.05 ppm (s).
CDCl
3
was added dropwise to a solution of [Rh(COD)
.2216 mmol) in CH Cl
was stirred for 20 min, concentrated, filtered, and finally treated
with Et as an or-
O (3 ꢁ 5 mL) to give 180 mg of [Rh(COD)(10a)]BF
ange powder. Yield: 92%, mp 178–179 °C. P{ H} NMR (121.495
2
]BF
4
0
2
2
(5 mL). The resulting orange solution
4
.10. [Rh(COD)(10c)]BF 11c
4
2
4
31
1
[
Rh(COD)(10c)]BF
4
was obtained by the procedure described
; yellow powder. Yield: 90%, mp 199–
P{1H} NMR (121.495 MHz, CDCl ): d = 35.88 (dd,
1
2
for [Rh(COD)(10a)]BF
4
MHz, CDCl
1
3
): d = 24.35 (dd, J(Rh,P) = 139.2 Hz, J(P,P) = 49.0 Hz),
3
1
1
2
2
00 °C.
3
40.73 ppm (dd, J(Rh,P) = 259.5 Hz, J(P,P) = 49.0 Hz).